BATON ROUGE, La. - Centocor Inc. has removed to the U.S. District Court for the Middle District of Louisiana a lawsuit alleging that its diabetes drug Remicade triggered Charcot-Marie-Tooth (CMT), a wasting neuromuscular disorder (Sheila B. Hidalgo, et al. v. Centocor Inc., No. 3:08-cv-115, M.D. La.). Full story on lexis.com (Source: LexisNexis® Mealey's™ Arthritis Drugs Legal News)

View the full article